Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 44.90%176.35K | -5.64%95.87K | 0.08%676.65K | 34.68%327.73K | -15.69%125.62K | -25.82%121.71K | -15.15%101.59K | -2.45%676.12K | 0.14%243.33K | 2.40%148.99K |
| Selling and administrative expenses | 56.36%130.26K | -7.63%57.11K | -9.19%351.77K | 15.09%120.14K | -20.37%86.5K | -11.83%83.31K | -22.58%61.83K | -22.15%387.35K | -39.85%104.38K | -5.33%108.63K |
| -General and administrative expense | 56.36%130.26K | -7.63%57.11K | -9.19%351.77K | 15.09%120.14K | -20.37%86.5K | -11.83%83.31K | -22.58%61.83K | -22.15%387.35K | -39.85%104.38K | -5.33%108.63K |
| Other operating expenses | 20.02%46.09K | -2.53%38.76K | 12.50%324.88K | 49.40%207.59K | -3.08%39.12K | -44.81%38.4K | -0.29%39.77K | 47.65%288.77K | 100.05%138.95K | 31.24%40.36K |
| Operating profit | -44.90%-176.35K | 5.64%-95.87K | -0.08%-676.65K | -34.68%-327.73K | 15.69%-125.62K | 25.82%-121.71K | 15.15%-101.59K | 2.45%-676.12K | -0.14%-243.33K | -2.40%-148.99K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | 515.87K | 31.93K | -643.60%-769.97K | -429.16%-781.84K | 13.18%11.88K | -186.00%-103.55K | -421.23%-147.75K | 108.29%10.49K | ||
| Gain on sale of security | ---12.42K | --31.93K | ---130K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --528.29K | ---- | -347.94%-661.84K | ---- | ---- | --0 | ---- | -11.93%-147.75K | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | 347.94%661.84K | ---- | ---- | ---- | ---- | --147.75K | ---- | ---- |
| -Less:Other special charges | ---528.29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | -50.52%21.88K | --10K | 13.18%11.88K | ---- | ---- | -53.85%44.21K | --0 | -28.56%10.49K |
| Income before tax | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 17.87%-113.75K | 7.22%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.09%-138.5K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 17.87%-113.75K | 7.22%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.09%-138.5K |
| Net income continuous operations | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 17.87%-113.75K | 7.22%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.09%-138.5K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 17.87%-113.75K | 7.22%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.09%-138.5K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 378.96%339.52K | 37.07%-63.94K | -85.54%-1.45M | -183.72%-1.11M | 17.87%-113.75K | 7.22%-121.71K | 14.56%-101.59K | -6.90%-779.67K | -98.53%-391.08K | 49.09%-138.5K |
| Diluted earnings per share | 0 | 0 | 0.00%-0.01 | 0.00%-0.01 | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0.00%-0.01 | 0.00%-0.01 | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.